Epic Sciences has raised $ 500 m in a series E funding round , led by private equity firm Blue Ox ##tech Partners , to develop its cancer diagnostic tests . The US labs will use the funding to create further diagnostic tests , known as liquid biopsies , which help determine the best course of treatment for patients with cancer .
Epic Sciences has secured $52m in a series E funding round, led by private equity firm Blue Ox Healthcare Partners, to develop its cancer diagnostic tests. The US company will use the funding to create further blood tests, known as liquid biopsies, which help determine the best course of treatment for patients with cancer.